Exploratory analyses of the associations between Ki-67 expression, lymph node metastasis, and prognosis in patients with esophageal squamous cell cancer
PeerJ · 2025
DOI: 10.7717/peerj.19062 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Jianqing Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China. Hauptthemen laut MEDLINE: Ki-67 Antigen, Esophageal Neoplasms, Lymphatic Metastasis, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Science and technology projects of Quanzhou city, Fujian provincial health technology project.
Abstract (Originalsprache)
Background
The relationships between Ki-67/MKI67 expression, lymph node metastasis (LNM), vascular invasion (VI), and perineural invasion (PI) in esophageal squamous cell cancer (ESCC) remain unclear. This retrospective cohort study was performed to evaluate the prognostic value of Ki-67 expression and its association with LNM in patients with resected ESCC.
Methods
The analysis included 168 patients with ESCC with available Ki-67 protein expression data. The patients were divided into Ki-67 high-expression group (Ki-67 High, 93 cases) and Ki-67 low-expression (Ki-67 Low, 75 cases) groups. Associations between Ki-67 expression and ESCC pathological features was assessed using chi-square test. Overall survival (OS) was compared between the two groups using Kaplan–Meier survival analysis and Cox proportional hazards model.
Results
Median follow-up duration was 33.5 months (range 3.0–60.0 months). High Ki-67 expression was significantly associated with poor OS in patients with ESCC compared to that of the low-expression in both univariate (hazard ratios (HR) = 3.42, 95% CI [2.22–5.27], P < 0.001) and multivariate analyses (HR = 1.98, 95% CI [1.33–2.94], P < 0.001). Furthermore, high Ki-67 expression was significantly associated with an increased risk of LNM ( χ 2 = 11.219, P = 0.011), VI ( χ 2 = 6.359, P = 0.012), and PI ( χ 2 = 8.877, P = 0.003).
Conclusions
High Ki-67 protein expression is associated with poor prognosis in ESCC. Increased Ki-67 expression significantly increases the risk of LNM, VI, and PI in ESCC, and thus may serve as an indication for adjuvant therapy in ESCC management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
- Department of Obstetrics and Gynecology, Quanzhou Medical College People's Hospital Affiliated, Quanzhou, Fujian, China.
- Department of Pathology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Förderung
- Natural Science Foundation of Fujian Province
- Science and technology projects of Quanzhou city
- Fujian provincial health technology project
- Nursery Fund Project of the Second Affiliated Hospital of Fujian Medical University
- School-level Project of Quanzhou Medical College
Zitieren
APA
Zheng, J., Huang, B., Chen, Y., Zeng, B., Xiao, L., & Wu, M. (2025). Exploratory analyses of the associations between Ki-67 expression, lymph node metastasis, and prognosis in patients with esophageal squamous cell cancer. PeerJ. https://doi.org/10.7717/peerj.19062
Vancouver
Zheng J, Huang B, Chen Y, Zeng B, Xiao L, Wu M. Exploratory analyses of the associations between Ki-67 expression, lymph node metastasis, and prognosis in patients with esophageal squamous cell cancer. PeerJ. 2025. doi:10.7717/peerj.19062
BibTeX
@article{Zheng2025,
author = {Zheng, Jianqing and Huang, Bifen and Chen, Ying and Zeng, Bingwei and Xiao, Lihua and Wu, Min},
title = {Exploratory analyses of the associations between Ki-67 expression, lymph node metastasis, and prognosis in patients with esophageal squamous cell cancer},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.19062}
}
EUVIMED